NEW YORK (GenomeWeb) – GlaxoSmithKline announced on Tuesday a $95 million investment to launch the Altius Institute for Biomedical Sciences, which will develop new technologies and approaches to elucidate how genes are controlled and how a cell's "operating system" functions in healthy and disease states. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.